α-Adrenoceptor agonists for the treatment of vasovagal syncope: A meta-analysis of worldwide published data

Acta Paediatrica, International Journal of Paediatrics

Volumn 98, Issue 7, 2009, Pages 1194-1200

  Liao, Ying ^a   Li, Xueying ^a   Zhang, Yanwu ^a   Chen, Stella ^b   Tang, Chaoshu ^c   Du, Junbao ^a,d  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^d BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

adrenoceptor agonists; Meta analysis; Randomized controlled trial; Vasovagal syncope

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ATRIAL NATRIURETIC FACTOR; ETILEFRINE; MIDODRINE; PLACEBO;

ARTICLE; AUTONOMIC NERVOUS SYSTEM; BODY POSITION; CARDIOVASCULAR SYSTEM; CLINICAL TRIAL; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; DRUG SELECTIVITY; FOLLOW UP; HEMODYNAMIC PARAMETERS; HUMAN; LOW DRUG DOSE; META ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYNCOPE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATATION;

ADRENERGIC ALPHA-AGONISTS; ETILEFRINE; HUMANS; MIDODRINE; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS AS TOPIC; SYNCOPE, VASOVAGAL;

EID: 66749111756     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2009.01289.x     Document Type: Article

References (33)

1. Ganzeboom KS, Mairuhu G, Reitsma JB, Linzer M, Wieling W, van Dijk N. Lifetime cumulative incidence of syncope in the general population: a study of 549 Dutch subjects aged 35-60 years. J Cardiovasc Electrophysiol 2006 17 : 1172 6.
2. Colman N, Nahm K, Ganzeboom KS, Shen WK, Reitsma J, Linzer M, et al. Epidemiology of reflex syncope. Clin Auton Res 2004 14 : 9 17.
3. Du JB. Mechanism and clinical diagnosis of vasovagal syncope in children. Chin J Med 2002 37 : 8 10.
4. Brignole M. Randomized clinical trials of neurally mediated syncope. J Cardiovasc Electropysiol 2003 14 : S64 9.
5. Di Gerolamo E, Di Iorio C, Sabatini O, Leonzio L, Barbone C, Barsotti A. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blinded, placebo-controlled study. J Am Coll Cardiol 1999 33 : 1227 30.
6. Zeng C, Zhu Z, Liu G, Hu W, Wang X, Yang C, et al. Randomized, double-blinded, placebo-controlled trial of oral enalapril in patients with neurally mediated syncope. Am Heart J 1998 136 : 852 8.
7. Parry SW, Kenny RA. The management of vasovagal syncope. Q J Med 1999 92 : 697 705.
8. Lee TM, Su SF, Chen MF, Liau CS. Usefulness of transdemal scopolamine for vasovagal syncope. Am J Cardiol 1996 78 : 480 2.
9. Morillo CA, Leitch JW, Yee R, Klein GL. A placebo-controlled trial of intravenous and oral disopyramide or prevention of neurally mediated syncope induced by head-up tilt. J Am Coll Cardiol 1993 22 : 1843 8.
10. Sheldon R, Stuart C, Sarah R, Klingenheben T, Krahn A, Morillo C, et al. Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope. Circulation 2006 113 : 1164 70.
11. Mahanonda N, Bhuripanyo K, Kangkagate C, Wansanit K, Kulchot B, Nademanee K, et al. Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results. Am Heart J 1995 130 : 1250 3.
12. Brignole M, Alboni P, Benditt DG, Bergfeldt L, Blanc JJ, Thomsen PE, et al. The Task Force on Syncope, European Society of Cardiology. Guidelines on management (diagnosis and treatment) of syncope-update 2004. Executive Summary. Eur Heart J 2004 25 : 2054 72.
13. Ward CR, Gray JC, Gilroy JJ, Kenny RA. Midodrine: a role in the management of neurocardiogenic syncope. Heart 1998 79 : 45 9.
14. Raviele A, Brignole M, Sutton R, Alboni P, Giani P, Menozzi C, et al. Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. Circulation 1999 99 : 1452 7.
15. Juni P, Altman DG, Egger M. Assessing the quality of controlled clinical trials. BMJ 2001 323 : 42 6.
16. Yu ZB, Han SP, Guo XR. Meta-analysis of inhaled nitric oxide for hypoxaemic respiratory failure in preterm infants. Chin J Evid Based Pediatr 2007 2 : 327 37.
17. Wu TX, Liu GJ. The definition, practice and report of allocation concealment and blinding. Chin J Evid-based Med 2007 7 : 222 4.
18. Liu JP. Compliance and intention-to-treat analysis in randomized controlled trial. Chin J TW Med 2003 23 : 884 6.
19. Moya A, Permanyer-Miralda G, Sagrista-Sauleda J, Carne X, Rius T, Mont L, et al. Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: results of a controlled study of etilefrine versus placebo. J Am Coll Cardiol 1995 25 : 65 9.
20. Perez-Lugones A, Schweikert R, Pavia S, Sra J, Akhtar M, Jaeger F, et al. Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope: a randomized control study. J Cardiovasc Electrophysiol 2001 12 : 935 8.
21. Kaufmann H, Saadia D, Voustianiouk A. Midodrine in neurally mediated syncope: a double-blind, randomized, crossover study. Ann Neurol 2002 52 : 342 5.
22. Zhang QY, Du JB, Tang CS. The efficacy of midodrine hydrochloride in the treatment of children with vasovagal syncope. J Pediatr 2006 149 : 777 80.
23. Nair N, Padder FA, Kantharia BK. Pathophysiology and management of neurocardiogenic syncope. Am J Manag Care 2003 9 : 327 34.
24. Blair PG. Neurocardiogenic syncope. N Engl J Med 2005 352 : 1004 10.
25. Ku BS. Pharmacology. Beijing : Peking University Med Press, 2004 : 105 9.
26. Parry SW, Kenny RA. The management of vasovagal syncope. Q J Med 1999 92 : 697 705.
27. Wei QM, Yao LM, FU XH. Treatment and mechanism of vasovagal syncope. Adv Cardiovasc Dis 2005 26 : 655 9.
28. Hainsworth R. Reflexes from the heart. Pkysiol Rev 1991 71 : 617 58.
29. Lamarre-Cliche M, du Souich P, de Champlain J, Larochelle P. Pharmacokinetic and pharmacodynamic effects of midodrine on blood pressure, the autonomic nervous system, and plasma natriuretic peptides: a prospective, randomized, single-blind, two-period, crossover, placebo-controlled study. Clin Ther 2008 30 : 1629 38.
30. Mellander S. Comparative studies on the adrenergic neuro-hormonal control of resistance and capacitance blood vessels in the cat. Acta Physiol Scand Suppl 1960 50 : 1 86.
31. Coleman AJ, Leary WP, Asmal AC. The cardiovascular effects of etilefrine. Eur J Clin Pharmacol 1975 8 : 41 5.
32. Mellander S. Comparative effects of acetylcholine, butyl-nor-synephrine (Vasculat), noradrenaline, and ethyl-adrianol (Effortil) on resistance capacitance and precapillary sphincter vessels and capillary filtration in cat skeletal muscle. Angiologia 1966 3 : 77 99.
33. Qu HQ, Lin S, Qiu MC. Brief introduction on studies bias of systematic reviews. Chin J Evid-based Med 2001 1 : 114 16.